Gene-delivery treatment for inherited high cholesterol
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests an experimental treatment that uses tiny particles to deliver a genetic message to help lower very high cholesterol caused by a rare inherited condition. It may offer a new option for people who have not responded to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old.
- Have a genetic diagnosis of familial hypercholesterolemia.
- Be in generally good health, without serious heart, lung, or other major conditions.
- Not have had prior gene, cell, or targeted therapy for your condition.
- Be willing to use effective contraception during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new gene therapy called NGGT006 for people with a genetic form of high cholesterol that doesn't improve with standard treatments. It aims to lower cholesterol levels and reduce the risk of heart problems.
This trial tests a new gene therapy called YOLT-101 for people with familial hypercholesterolemia, a genetic condition that causes very high cholesterol. The treatment aims to lower cholesterol levels and reduce heart risks.
This trial focuses on people with familial hypercholesterolemia (FH), an inherited condition that causes very high cholesterol. It aims to better understand and manage severe cholesterol problems that raise heart risk, especially in families.
This trial focuses on people referred to a cholesterol (lipid) clinic to help identify inherited high cholesterol. It tests an “interpretive comment” approach to nudge detection—meaning it may help clinicians recognize who is most likely to have familial hypercholesterolemia.
This trial helps people with high cholesterol or a history of heart disease find the best treatment to lower their risk of future heart problems. It tests a program to optimize lipid-lowering therapy.
This trial tests a one-time gene therapy to lower extremely high cholesterol in people with a rare inherited condition. It may help reduce heart attack risk in those who haven't responded to standard treatments.
Hear when a new Familial Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.